Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Evaluation of Prediction Model Survival Spinal Epidural Metastases

NCT06411015 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT06411015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06411015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Evaluation of Prediction Model Survival Spinal Epidural Metastases
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Completed
Start date
January 1, 2021
Completion date
May 1, 2024
Enrollment
428 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

predictive cancer model